Pharmafile Logo

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

During the COVID-19 pandemic, multiple sclerosis (MS) experts were receiving many questions regarding the safety and efficacy of COVID-19 vaccination in patients receiving treatment for MS. The challenge was developing robust guidance in a timely manner with a goal of providing clarity on vaccine timing, efficacy, and safety, to support healthcare professionals and their patients.

An international Steering Committee of 10 MS experts came together to discuss, refine, and finalise 13 clinical recommendations. A further 28 MS experts from 19 countries also voted on the recommendations and helped to reach robust consensus through a virtual voting platform within a 90-day timeframe.

“Merck KGaA and Bedrock identified a beautifully simple solution to a pressing need. The judges recognised that achieving actional consensus on guidelines is always challenging, which is exacerbated by HCPs’ workloads, but the results achieved here are impressive. The approach was bold and imaginative, and the execution very well planned and delivered” PMEA Judging Panel 2022.

Stephen Marchant, MD of Bedrock said “We would like to add congratulations to Hashem Salloukh for partnering and trusting us with this critical project that provided a clear patient benefit. I would also like to thank my Bedrock team. This award is a testament to their freethinking, agility, and our belief that no two business challenges are the same.”

If you are looking for a team of freethinkers with bold and imaginative approaches to medical communications get in touch  freethinking@bedrock-health.com

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Bedrock creates waves

The Bedrock team were awash with ideas at their summer watersports and BBQ event. All were Bravely Bedrock in a host of activities – including wakeboarding, paddle boarding and taming...

Bedrock LEAPs to new heights

What do our future leaders say about LEAP?

Bedrock Group strengthens its senior team

Bedrock strengthen its management team with the recruitment of two senior roles

A postcard from Cannes

This week sees the annual Cannes Lions International Festival of Creativity, bringing together leading creative talent from across the globe to learn, share and inspire each other. Until recently, pharmaceuticals...

A variety of backgrounds, a unified purpose

How did Bedrock become Bedrock? We asked members of the Bedrock team how they found their way into the (somewhat hidden) world of medical communications, and what they love about...

Wanda Lesowiec did it. Could you?

How a background in pharma can mean a bright future in medical communications

Am I wrong to be apprehensive about gene therapy?

Is the introduction of gene therapy going to be smooth sailing? Origin's Strategic Solutions Director, Su Smith, shares her thoughts.

Bedrock Group announces the launch of Origins, a health experience research company

Bedrock Group is proud to announce the launch of Origins, a health experience research company.

Artificial Intelligence: a new character in the storytelling of drug development and discovery?

Written by Edward Jones, Junior Medical Writer. Bedrock is dedicated to creating valuable and powerful stories to engage audiences that drive an improvement in the provision of health. This focus...

The playbook of a 'reluctant creative'

Are we all capable of being creative?